Coronaridine congeners modulate mitochondrial α3β4* nicotinic acetylcholine receptors with different potency and through distinct intra-mitochondrial pathways

Hugo R. Arias, Olena Lykhmus, Kateryna Uspenska, Maryna Skok

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

In contrast to plasma membrane-expressed nicotinic acetylcholine receptors (nAChRs), mitochondrial nAChRs function in an ion-independent manner by triggering intra-mitochondrial kinases that regulate the release of cytochrome c (Cyt c), an important step in cellular apoptosis. The aim of this study is to determine the structural requirements for mitochondrial α3β4* nAChR activation by measuring the modulatory effects of two noncompetitive antagonists of these receptors, (+)-catharanthine and (±)-18-methoxycoronaridine [(±)-18-MC], on Cyt c release from wild-type and α7−/− mice mitochondria. The sandwich ELISA results indicated that α3β4* nAChRs are present in liver mitochondria in higher amounts compared to that in brain mitochondria and that these receptors are up-regulated in α7−/− mice. Correspondingly, (±)-18-MC decreased Cyt c release from liver mitochondria of wild-type mice and from brain and liver mitochondria of α7−/− mice. The effect in wild-type mice mitochondria was mediated mainly by the Src-dependent pathway, regulating the apoptogenic activity of reactive oxygen species, while in α7−/− mice mitochondria, (±)-18-MC strongly affected the calcium-calmodulin kinase II-dependent pathway. In contrast, (+)-catharanthine was much less potent than (±)-18-MC and triggered several signaling pathways, suggesting the involvement of multiple nAChR subtypes. These results show for the first time that noncompetitive antagonists can induce mitochondrial α3β4* nAChR signaling, giving a more comprehensive understanding on the function of intracellular nAChR subtypes.

Original languageEnglish
Pages (from-to)26-32
Number of pages7
JournalNeurochemistry International
Volume114
DOIs
StatePublished - 1 Mar 2018
Externally publishedYes

Fingerprint

Nicotinic Receptors
Liver Mitochondrion
Mitochondria
Cytochromes c
Calcium-Calmodulin-Dependent Protein Kinases
Brain
coronardine
Reactive Oxygen Species
Phosphotransferases
Enzyme-Linked Immunosorbent Assay
Cell Membrane
Ions
Apoptosis
Calcium

Keywords

  • (+)-Catharanthine
  • (±)-18-Methoxycoronaridine
  • Coronaridine congeners
  • Mitochondria-driven apoptosis
  • Mitochondrial nicotinic acetylcholine receptors

Cite this

@article{26ddab6e3b4a4684a069d7c202dc823d,
title = "Coronaridine congeners modulate mitochondrial α3β4* nicotinic acetylcholine receptors with different potency and through distinct intra-mitochondrial pathways",
abstract = "In contrast to plasma membrane-expressed nicotinic acetylcholine receptors (nAChRs), mitochondrial nAChRs function in an ion-independent manner by triggering intra-mitochondrial kinases that regulate the release of cytochrome c (Cyt c), an important step in cellular apoptosis. The aim of this study is to determine the structural requirements for mitochondrial α3β4* nAChR activation by measuring the modulatory effects of two noncompetitive antagonists of these receptors, (+)-catharanthine and (±)-18-methoxycoronaridine [(±)-18-MC], on Cyt c release from wild-type and α7−/− mice mitochondria. The sandwich ELISA results indicated that α3β4* nAChRs are present in liver mitochondria in higher amounts compared to that in brain mitochondria and that these receptors are up-regulated in α7−/− mice. Correspondingly, (±)-18-MC decreased Cyt c release from liver mitochondria of wild-type mice and from brain and liver mitochondria of α7−/− mice. The effect in wild-type mice mitochondria was mediated mainly by the Src-dependent pathway, regulating the apoptogenic activity of reactive oxygen species, while in α7−/− mice mitochondria, (±)-18-MC strongly affected the calcium-calmodulin kinase II-dependent pathway. In contrast, (+)-catharanthine was much less potent than (±)-18-MC and triggered several signaling pathways, suggesting the involvement of multiple nAChR subtypes. These results show for the first time that noncompetitive antagonists can induce mitochondrial α3β4* nAChR signaling, giving a more comprehensive understanding on the function of intracellular nAChR subtypes.",
keywords = "(+)-Catharanthine, (±)-18-Methoxycoronaridine, Coronaridine congeners, Mitochondria-driven apoptosis, Mitochondrial nicotinic acetylcholine receptors",
author = "Arias, {Hugo R.} and Olena Lykhmus and Kateryna Uspenska and Maryna Skok",
year = "2018",
month = "3",
day = "1",
doi = "10.1016/j.neuint.2017.12.008",
language = "English",
volume = "114",
pages = "26--32",
journal = "Neurochemistry International",
issn = "0197-0186",
publisher = "Elsevier Ltd",

}

Coronaridine congeners modulate mitochondrial α3β4* nicotinic acetylcholine receptors with different potency and through distinct intra-mitochondrial pathways. / Arias, Hugo R.; Lykhmus, Olena; Uspenska, Kateryna; Skok, Maryna.

In: Neurochemistry International, Vol. 114, 01.03.2018, p. 26-32.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Coronaridine congeners modulate mitochondrial α3β4* nicotinic acetylcholine receptors with different potency and through distinct intra-mitochondrial pathways

AU - Arias, Hugo R.

AU - Lykhmus, Olena

AU - Uspenska, Kateryna

AU - Skok, Maryna

PY - 2018/3/1

Y1 - 2018/3/1

N2 - In contrast to plasma membrane-expressed nicotinic acetylcholine receptors (nAChRs), mitochondrial nAChRs function in an ion-independent manner by triggering intra-mitochondrial kinases that regulate the release of cytochrome c (Cyt c), an important step in cellular apoptosis. The aim of this study is to determine the structural requirements for mitochondrial α3β4* nAChR activation by measuring the modulatory effects of two noncompetitive antagonists of these receptors, (+)-catharanthine and (±)-18-methoxycoronaridine [(±)-18-MC], on Cyt c release from wild-type and α7−/− mice mitochondria. The sandwich ELISA results indicated that α3β4* nAChRs are present in liver mitochondria in higher amounts compared to that in brain mitochondria and that these receptors are up-regulated in α7−/− mice. Correspondingly, (±)-18-MC decreased Cyt c release from liver mitochondria of wild-type mice and from brain and liver mitochondria of α7−/− mice. The effect in wild-type mice mitochondria was mediated mainly by the Src-dependent pathway, regulating the apoptogenic activity of reactive oxygen species, while in α7−/− mice mitochondria, (±)-18-MC strongly affected the calcium-calmodulin kinase II-dependent pathway. In contrast, (+)-catharanthine was much less potent than (±)-18-MC and triggered several signaling pathways, suggesting the involvement of multiple nAChR subtypes. These results show for the first time that noncompetitive antagonists can induce mitochondrial α3β4* nAChR signaling, giving a more comprehensive understanding on the function of intracellular nAChR subtypes.

AB - In contrast to plasma membrane-expressed nicotinic acetylcholine receptors (nAChRs), mitochondrial nAChRs function in an ion-independent manner by triggering intra-mitochondrial kinases that regulate the release of cytochrome c (Cyt c), an important step in cellular apoptosis. The aim of this study is to determine the structural requirements for mitochondrial α3β4* nAChR activation by measuring the modulatory effects of two noncompetitive antagonists of these receptors, (+)-catharanthine and (±)-18-methoxycoronaridine [(±)-18-MC], on Cyt c release from wild-type and α7−/− mice mitochondria. The sandwich ELISA results indicated that α3β4* nAChRs are present in liver mitochondria in higher amounts compared to that in brain mitochondria and that these receptors are up-regulated in α7−/− mice. Correspondingly, (±)-18-MC decreased Cyt c release from liver mitochondria of wild-type mice and from brain and liver mitochondria of α7−/− mice. The effect in wild-type mice mitochondria was mediated mainly by the Src-dependent pathway, regulating the apoptogenic activity of reactive oxygen species, while in α7−/− mice mitochondria, (±)-18-MC strongly affected the calcium-calmodulin kinase II-dependent pathway. In contrast, (+)-catharanthine was much less potent than (±)-18-MC and triggered several signaling pathways, suggesting the involvement of multiple nAChR subtypes. These results show for the first time that noncompetitive antagonists can induce mitochondrial α3β4* nAChR signaling, giving a more comprehensive understanding on the function of intracellular nAChR subtypes.

KW - (+)-Catharanthine

KW - (±)-18-Methoxycoronaridine

KW - Coronaridine congeners

KW - Mitochondria-driven apoptosis

KW - Mitochondrial nicotinic acetylcholine receptors

UR - http://www.scopus.com/inward/record.url?scp=85044371876&partnerID=8YFLogxK

U2 - 10.1016/j.neuint.2017.12.008

DO - 10.1016/j.neuint.2017.12.008

M3 - Article

C2 - 29277577

AN - SCOPUS:85044371876

VL - 114

SP - 26

EP - 32

JO - Neurochemistry International

JF - Neurochemistry International

SN - 0197-0186

ER -